In this two-page edition of Pharmacy Pearls, we review the network-wide pharmacy savings opportunities identified by the AHP Pharmacy Team for 2025. There continues to be opportunities in several therapeutic…
Each year, the National Committee for Quality Assurance (NCQA) invites public feedback on proposed changes to HEDIS measures. This provides a valuable opportunity for healthcare stakeholders to weigh in on…
The 2025 Care Management (CM) Redesign focuses on operationalizing a structured, population health approach to identify and manage adult patients who are eligible for and likely to benefit from CM…
Understanding Osteoporosis Osteoporosis is the most common metabolic bone disease in the United States, affecting millions of individuals, particularly postmenopausal women and older adults. Despite its prevalence, osteoporosis remains an…
The Practice Managers Meetings are a great opportunity to learn best practices from other practice managers, billing and office staff, get important updates on new and continuing AHP initiatives, and…
The Monroe County Medical Society (MCMS) is conducting a survey to better understand the perceptions of its members and stakeholders and plan for the future. As many of you know,…
March is National Women’s History, Developmental Disabilities Awareness & Irish American Heritage Month. March is a month of celebration, reflection, and advocacy, with three important observances: National Women’s History Month,…
Accountable Health Partners is actively progressing with our phased transition to Health Catalyst, our new population health management partner. The AHP team is collaborating closely with Health Catalyst to explore…
AHP is dedicated to continuously improving patient care, and our quality measures reflect this commitment. After successful negotiations with payers, we have finalized our quality metrics for 2025. These measures,…
In this edition of Pharmacy Pearls, you will find a review of the treatment recommendations for acute uncomplicated cystitis and pyelonephritis, including dosing, duration of therapy, and clinical considerations for…
